Comments on this legislation    Post new comment    Text and Analysis    Add to Watch List 
  Previous   Next 

• Introduced by Rep. Kathy Angerer (D) on October 27, 2009, to exclude from the gross receipts basis of the Michigan Business Tax receipts that are received by health care providers from the administration of antineoplastic drugs and other cancer chemotherapy, biological monitoring, therapeutic agents, and other supportive drugs given to cancer or blood disorder patients.
  • Referred to the House Tax Policy Committee on October 27, 2009.
    • Reported in the House on December 2, 2009, without amendment and with the recommendation that the bill pass.
• Passed 102 to 2 in the House on June 24, 2010, to exclude from the gross receipts basis of the Michigan Business Tax receipts that are received by health care providers from the administration of antineoplastic drugs and other cancer chemotherapy, biological monitoring, therapeutic agents, and other supportive drugs given to cancer or blood disorder patients.
  Who Voted "Yes" and Who Voted "No"
• Received in the Senate on June 29, 2010.
  • Referred to the Senate Finance Committee on June 29, 2010.